New and evolving concepts in the neurotoxicology of lead

Toxicology and Applied Pharmacology

Volumn 225, Issue 1, 2007, Pages 1-27

  White, L D ^a   Cory Slechta, D A ^b   Gilbert, M E ^c   Tiffany Castiglioni, E ^d   Zawia, N H ^e   Virgolini, M ^b   Rossi George, A ^b   Lasley, S M ^f   Qian, Y C ^d   Basha, Md Riyaz ^e  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

^e UNIVERSITY OF RHODE ISLAND   (United States)

^f UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Alzheimer's disease; Amyloid protein; Chaperones; Conformational disease; Hypothalamic pituitary adrenal axis; Lead; Long term potentiation; Stress; Synaptic plasticity

Indexed keywords

GLUCOCORTICOID; GLUCOSE REGULATED PROTEIN 78; GLUTAMIC ACID; INTERLEUKIN 6; LEAD; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ALZHEIMER DISEASE; ASTROCYTE; COGNITIVE DEFECT; DOPAMINERGIC SYSTEM; ENVIRONMENTAL EXPOSURE; EPIGENETICS; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LEARNING; LONG TERM POTENTIATION; MATERNAL STRESS; MEMORY; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROTOXICOLOGY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN SECRETION; REVIEW; SOCIOECONOMICS;

RODENTIA;

EID: 35649023261     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.08.001     Document Type: Review

References (238)

1. Adler N.E., and Ostrove J.M. Socioeconomic status and health: what we know and what we don't. Ann. N.Y. Acad. Sci. 896 (1999) 3-15
2. Adler N.E., and Newman K. Socioeconomic disparities in health: pathways and policies. Inequality in education, income, and occupation exacerbates the gaps between the health "haves" and "have-nots". Health Aff. (Millwood) 21 (2002) 60-76
3. Adler N.E., Boyce T., Chesney M.A., Cohen S., Folkman S., Kahn R.L., and Syme S.L. Socioeconomic status and health. The challenge of the gradient. Am. Psychol. 49 (1994) 15-24
4. Afano D.P., and Petit T.L. Neonatal lead exposure alters the dendritic development of hippocampal dentate granule cells. Exp. Neurol. 75 (1982) 275-288
5. Alkondon M., Costa A.C.S., Radhakrishnan V., Aronstam R.S., and Albuquerque E.X. Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett. 261 (1990) 124-130
6. Altmann L., Weinsberg F., Sveinsson K., Lilienthal H., Weigand H., and Winneke G. Impairment of long-term potentiation and learning following chronic lead exposure. Toxicol. Lett. 66 1 (1993) 105-112
7. Ancolio K., Dumanchin C., Barelli H., Warter J.M., Bric E.A., Campion D., Frebourg T., and Checler F. Unusual phenotypic alteration of beta amyloid precursor protein (βAPP) maturation by a new Val-715→Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4119-4124
8. Atchison W.D., and Narahashi T. Mechanism of action of lead on neuromuscular junction. Neurotoxicology 5 (1984) 267-282
9. Barker D.J. Fetal origins of cardiovascular disease. Ann. Med. Supl. 1 (1999) 3-6
10. Barker D.J. Fetal programming of coronary heart disease. Trends Endocrinol. Metab. 13 (2002) 364-368
11. Barker D.J. Developmental origins of adult health and disease. J. Epidemiol. Community Health 58 (2004) 114-115
12. Barker D.J., Winter P.D., Osmond C., Margetts B., and Simmonds S.J. Weight in infancy and death from ischaemic heart disease. Lancet 2 8663 (1989) 577-580
13. Barone Jr. S., Stanton M.E., and Mundy W.R. Neurotoxic effects of neonatal triethyltin (TET) exposure are exacerbated with aging. Neurobiol. Aging 16 (1995) 723-735
14. Basha M.R., Wei W., Bakheet S.A., Benitez N., Siddiqi H.K., Ge Y., Lahiri D.K., and Zawia N.H. The fetal-basis of amyloidogenesis: exposure to lead and latent over-expression of amyloid precursor protein and β-amyloid in the aging brain. J. Neurosci. 25 (2005) 823-829
15. Bellinger D.C. Teratogen update: lead and pregnancy. Birth Defects Res. A, Clin. Mol. Teratol. 73 (2005) 409-420
16. Bellinger D.C., and Bellinger A.M. Childhood lead poisoning: the tortuous path from science to policy. J. Clin. Invest. 116 (2006) 853-857
17. Bellinger D., Sloman J., Leviton A., Rabinowitz M., Needlemen H.L., and Waternaux C. Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics 87 (1991) 219-227
18. Bertolotti A., Zhang Y., Hendershot L.M., Harding H.P., and Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2 (2000) 326-332
19. Bertram L., and Tanzi R.E. Alzheimer's disease: one disorder, too many genes?. Hum. Mol. Genet. 13 (2004) R135-R141
20. Bilbo S.D., Levkoff L.H., Mahoney J.H., Watkins L.R., Rudy J.W., and Maier S.F. Neonatal infection induces memory impairments following an immune challenge in adulthood. Behav. Neurosci. 119 (2005) 293-301
21. Bissonnette C.J., Klegeris A., McGeer P.L., and McGeer E.G. Interleukin 1alpha and interleukin 6 protect human neuronal SH-SY5Y cells from oxidative damage. Neurosci. Lett. 361 (2004) 40-43
22. Bliss T.V.P., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
23. Boksa P., and El-Khodor B.F. Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders. Neurosci. Biobehav. Rev. 27 (2003) 91-101
24. Bolin L.M., Strycharska-Orczyk I., Murray R., Langston J.W., and Di Monte D. Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. J. Neurochem. 83 (2002) 167-175
25. Bolin C.M., Basha R., Cox D., Zawia N.H., Maloney B., Lahiri D.K., and Cardozo-Pelaez F. Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. FASEB J. 20 (2006) 788-790
26. Bradley R.H., and Corwyn R.F. Socioeconomic status and child development. Ann. Rev. Psychol. 53 (2002) 371-399
27. Braga M.F.M., Pereira E.F.R., and Albuquerque E.X. Nanomolar concentrations of lead inhibit glutamatergic and GABAergic transmission in hippocampal neurons. Brain Res. 826 (1999) 22-34
28. Braga M.F.M., Pereira E.F.R., Marchioro M., and Albuquerque E.X. Lead increases tetrodotoxin-insensitive spontaneous release of glutamate and GABA from hippocampal neurons. Brain Res. 826 (1999) 10-21
29. 2+ reduces voltage- and N-methyl-d-aspartate (NMDA)-activated calcium channel currents. Cell. Mol. Neurobiol. 14 (1994) 711-722
30. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., and Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10061-10065
31. Canfield R.L., Henderson C.R., Cory-Slechta D.A., Cox C., Jusko T.A., and Lanphear B.P. Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. New Engl. J. Med. 348 (2003) 1517-1526
32. Canfield R.L., Gendle M.H., and Cory-Slechta D.A. Impaired neuropsychological functioning in lead-exposed children. Dev. Neuropsychol. 26 (2004) 513-540
33. Cao Y.X., Jean J.C., and Williams M.C. Cytosine methylation of an Sp1 site contributes to organ-specific and cell-specific regulation of expression of the lung epithelial gene t1alpha. Biochem. J. 350 (2000) 883-890
34. Carrell R.W., and Lomas D.A. Conformational disease. Lancet 350 (1997) 134-138
35. Chrousos G.C.E., and Kino T. Editorial: Glucocorticoid action networks-an introduction to systems biology. J. Clin. Endocrinol. Metab. 89 (2004) 563-564
36. Clark S.J., Harrison J., and Molloy P.L. Sp1 binding is inhibited by (m)Cp(m)CpG methylation. Gene 195 (1997) 67-71
37. Cline H.T., Witte S., and Jones K.W. Low lead levels stunt neuronal growth in a reversible manner. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9915-9920
38. Collingridge G.L., and Bliss T.V.P. NMDA receptors - their role in long-term potentiation. Trends Neuropharm. 10 (1987) 288-293
39. Cohn J., and Cory-Slechta D.A. Subsensitivity of lead-exposed rats to the accuracy-impairing and rate-altering effects of MK-801 on a multiple schedule of repeated learning and performance. Brain Res. 600 (1993) 208-218
40. Cook D.G., Forman M.S., Sung J.C., Leight S., Kolson D.L., Iwatsubo T., Lee V.M., and Doms R.W. Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. 3 (1997) 1021-1023
41. Cookman G.R., King W., and Regan C.M. Chronic low-level lead exposure impairs embryonic to adult conversion of the neural cell adhesion molecule. J. Neurochem. 49 (1987) 399-403
42. Cory-Slechta D.A. MK-801 subsensitivity following postweaning lead exposure. Neurotoxicology 16 (1995) 83-95
43. Cory-Slechta D.A. Postnatal lead exposure and MK-801 sensitivity. Neurotoxicology 18 (1997) 209-220
44. Cory-Slechta D.A. Studying toxicants as single chemicals: does this strategy adequately identify neurotoxic risk?. Neurotoxicology 26 (2005) 491-510
45. Cory-Slechta D.A., Virgolini M.B., Thiruchelvam M., Weston D.D., and Bauter M.R. Maternal stress modulates effects of developmental lead exposure. Environ. Health Perspect. 112 (2004) 717-730
46. Dalman C., Allebeck P., Cullberg J., Grunewald C., and Koster M. Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch. Gen. Psychiatry 56 (1999) 234-240
47. Dave V., Vitarella D., Aschner J.L., Fletcher P., Kimelberg H.K., and Aschner M. Lead increases inositol 1,4,5-trisphosphate levels but does not interfere with calcium transients in primary rat astrocytes. Brain Res. 618 (1993) 9-18
48. de Vellis J., McGinnis J.F., and Cole R. Selective effects of lead on the hormonal regulation of glial cell differentiation in cell culture. Prog. Clin. Biol. Res. 253 (1987) 217-227
49. Deng W., McKinnon R.D., and Poretz R.D. Lead exposure delays the differentiation of oligodendroglial progenitors in vitro. Toxicol. Appl. Pharmacol. 174 (2001) 235-244
50. Dietert R.R., and Piepenbrink M.S. Lead and immune function. Crit. Rev. Toxicol. 36 (2006) 359-385
51. Duckett S., Galle P., and Kradin R. The relationship between Parkinson syndrome and vascular siderosis: an electron microprobe study. Ann. Neurol. 2 (1977) 225-229
52. Eckman C.B., Mehta N.D., Crook R., Perez-tur J., Prihar G., Pfeiffer E., Graff-Radford N., Hinder P., Yager D., Zenk B., Refolo L.M., Prada C.M., Younkin S.G., Hutton M., and Hardy J. A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43). Hum. Mol. Genet. 6 (1997) 2087-2089
53. Engle M.J., and Volpe J.J. Glutamine synthetase activity of developing astrocytes is inhibited in vitro by very low concentrations of lead. Brain Res. Dev. Brain Res. 55 (1990) 283-287
54. 2+ blocks calcium currents of cultured dorsal root ganglion cells. Neurosci. Lett. 129 (1991) 103-106
55. Fitsanakis V.A., and Aschner M. The importance of glutamate, glycine, and gamma-aminobutyric acid transport and regulation in manganese, mercury and lead neurotoxicity. Toxicol. Appl. Pharmacol. 204 (2005) 343-354
56. Gatz M., Pedersen N.L., Berg S., Johansson B., Johansson K., Mortimer J.A., Posner S.F., Viitanen M., Winblad B., and Ahlbom A. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 52 (1997) M117-M125
57. Gatz M., Fratiglioni L., Johansson B., Berg S., Mortimer J.A., Reynolds C.A., Fiske A., and Pedersen N.L. Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study. Neurobiol. Aging 26 (2005) 439-447
58. Gilbert M.E., and Mack C.M. The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat. Brain Res. 519 (1990) 89-96
59. Gilbert M.E., and Mack C.M. Chronic developmental lead exposure accelerated decay of long-term potentiation in rat dentate gyrus in vivo. Brain Res. 789 (1998) 139-149
60. Gilbert M.E., and Lasley S.M. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo. Neurotoxicol. Teratol. 29 (2007) 385-393
61. 2+) exposure increases threshold for long-term potentiation in the rat dentate gyrus in vivo. Brain Res. 736 (1996) 125-134
62. Gilbert M.E., Mack C.M., and Lasley S.M. The influence of developmental period of lead exposure on long-term potentiation in the rat dentate gyrus in vivo. Neurotoxicology 20 (1999) 57-70
63. Gilbert M.E., Mack C.M., and Lasley S.M. Developmental lead exposure reduces the magnitude of long-term potentiation: a dose-response analysis. Neurotoxicology 20 (1999) 71-82
64. Gilbert M.E., Kelly M.E., Samsam T.E., and Goodman J.H. Chronic developmental lead exposure reduces neurogenesis in adult rat hippocampus but does not impair spatial learning. Toxicol. Sci. 86 (2005) 365-374
65. Glenner G.G., and Wong C.W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122 (1984) 1131-1135
66. Gluckman P.D., and Hanson M.A. Living with the past: evolution, development, and patterns of disease. Science 305 (2004) 1733-1736
67. Goldgaber D., Lerman M.I., McBride W.O., Saffiotti U., and Gajdusek D.C. Isolation, characterization, and chromosomal localization of human brain cDNA clones coding for the precursor of the amyloid of brain in Alzheimer's disease, Down's syndrome and aging. J. Neural Transm., Suppl. 24 (1987) 23-28
68. Gonick H.C. Lead, renal disease and hypertension. Am. J. Kidney Dis. 40 (2002) 202-204
69. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., Brown G.G., and Richardson R.J. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 48 (1997) 650-658
70. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., Brown G.G., and Richardson R.J. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 20 (1999) 239-247
71. Greenfield J.P., Tsai J., Gouras G.K., Hai B., Thinakaran G., Checler F., Sisodia S.S., Greengard P., and Xu H. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 742-747
72. Gruol D.L., and Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15 (1997) 307-339
73. 3H]MK-801 binding to the NMDA receptor-gated ionophore: In vitro and in vivo studies. Neurosci. Lett. 148 (1992) 27-30
74. 3H]MK801 binding sites in adult rat forebrain. Eur. J. Pharmacol. 248 (1993) 273-275
75. (2+). Brain Res. Mol. Brain Res. 76 (2000) 299-305
76. Haass C., Hung A.Y., Selkoe D.J., and Teplow D.B. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J. Biol. Chem. 269 (1994) 17741-17748
77. Hanisch U.K. Microglia as a source and target of cytokines. Glia 40 (2002) 140-155
78. Haraguchi T., Ishizu H., Takehisa Y., Kawai K., Yokota O., Terada S., Tsuchiya K., Ikeda K., Morita K., Horike T., Kira S., and Kuroda S. Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC): the possibility of lead neurotoxicity. NeuroReport 12 (2001) 3887-3890
79. Harry G.J., Billingsley M., Bruinink A., Campbell I.L., Classen W., Dorman D.C., Galli C., Ray D., Smith R.A., and Tilson H.A. In vitro techniques for the assessment of neurotoxicity. Environ. Health Perspect. 106 Suppl 1 (1998) 131-158
80. Hartmann T., Bieger S.C., Bruhl B., Tienari P.J., Ida N., Allsop D., Roberts G.W., Masters C.L., Dotti C.G., Unsicker K., and Beyreuther K. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat. Med. 3 (1997) 1016-1020
81. Ho S., Tang W., de Frausto B., and Prins G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 66 (2006) 5624-5632
82. Hoffman P.W., and Chernak J.M. DNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid protein gene promoter. Nucleic Acids Res. 23 (1995) 2229-2235
83. Holtzman D., DeVries C., Nguyen H., Olson J., and Bensch K. Maturation of resistance to lead encephalopathy: cellular and subcellular mechanisms. Neurotoxicology 5 (1984) 97-124
84. Holtzman D., Olson J.E., DeVries C., and Bensch K. Lead toxicity in primary cultured cerebral astrocytes and cerebellar granular neurons. Toxicol. Appl. Pharmacol. 89 (1987) 211-225
85. Hori O., Matsumoto M., Kuwabara K., Maeda Y., Ueda H., Ohtsuki T., Kinoshita T., Ogawa S., Stern D.M., and Kamada T. Exposure of astrocytes to hypoxia/reoxygenation enhances expression of glucose-regulated protein 78 facilitating astrocyte release of the neuroprotective cytokine interleukin 6. J. Neurochem. 66 (1996) 973-979
86. Hu H., Rabinowitz M., and Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ. Health Perspect. 106 (1998) 1-8
87. Ishihara K., Alkondon M., Montes J.G., and Albuquerque E.X. Ontogenically related properties of N-methyl-d-aspartate receptors in rat hippocampal neurons and the age-specific sensitivity of developing neurons to lead. J. Pharmacol. Exp. Ther. 273 (1995) 1459-1470
88. Jaako-Movitts K., Zharkovsky T., Romantchik O., Jurgenson M., Merisalu E., Heidmets L.T., and Zharkovsky A. Developmental lead exposure impairs contextual fear conditioning and reduces adult hippocampal neurogenesis in the rat brain. Int. J. Dev. Neurosci. 23 (2005) 627-635
89. Jason K.M., and Kellogg C.K. Neonatal lead exposure: effects on development of behavior and striatal dopamine neurons. Pharmacol. Biochem. Behav. 15 (1981) 641-649
90. Jeffery K.J., Abraham W.C., Dragunow M., and Mason S.E. Induction of fos-like immunoreactivity and the maintenance of long-term potentiation in the dentate gyrus of unanesthetized rats. Mol. Brain Res. 8 (1990) 267-274
91. Joels M., and de Kloet E.R. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog. Neurobiol. 43 (1994) 1-36
92. Kakimura J., Kitamura Y., Takata K., Tsuchiya D., Taniguchi T., Gebicke-Haerter P.J., Smith M.A., Perry G., and Shimohama S. Possible involvement of ER chaperone Grp78 on reduced formation of amyloid-beta deposits. Ann. N.Y. Acad. Sci. 977 (2002) 327-332
93. Kamel F., Umbach D.M., Munsat T.L., Shefner J.M., Hu H., and Sandler D.P. Lead exposure and amylotrophic lateral sclerosis. Epidemiology 13 (2002) 311-319
94. Kapuku G.L., Treiber F.A., and Davis H.C. Relationships among socioeconomic status, stress induced changes in cortisol, and blood pressure in African American males. Ann. Behav. Med. 24 (2002) 320-325
95. Katayama T., Imaizumi K., Sato N., Miyoshi K., Kudo T., Hitomi J., Morihara T., Yoneda T., Gomi F., Mori Y., Nakano Y., Takeda J., Tsuda T., Itoyama Y., Murayama O., Takashima A., St George-Hyslop P., Takeda M., and Tohyama M. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat. Cell Biol. 1 (1999) 479-485
96. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13 (1999) 1211-1233
97. Kempermann G., and Kronenberg G. Depressed new neurons-adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol. Psychiatry 54 (2003) 499-503
98. Kern M., and Audesirk G. Inorganic lead may inhibit neurite development in cultured rat hippocampal neurons through hyperphosphorylation. Toxicol. Appl. Pharmacol. 134 (1995) 111-123
99. Kimata Y., Kimata Y.I., Shimizu Y., Abe H., Farcasanu I.C., Takeuchi M., Rose M.D., and Kohno K. Genetic evidence for a role of BiP/Kar2 that regulates Ire1 in response to accumulation of unfolded proteins. Mol. Biol. Cell 14 (2003) 2559-2569
100. Kober T.E., and Cooper G.P. Lead competitively inhibits calcium-dependent synaptic transmission in the bullfrog sympathetic ganglion. Nature 262 (1976) 704-705
101. Kopito R.R., and Ron D. Conformational disease. Nat. Cell Biol. 2 (2000) E207-E209
102. Kramar E.A., Lin B., Lin C.Y., Arai A.C., Gall C.M., and Lynch G. A novel mechanism for the facilitation of theta-induced long-term potentiation by brain-derived neurotrophic factor. J. Neurosci. 24 (2004) 5151-5161
103. Kudo T., Okumura M., Imaizumi K., Araki W., Morihara T., Tanimukai H., Kamagata E., Tabuchi N., Kimura R., Kanayama D., Fukumori A., Tagami S., Okochi M., Kubo M., Tanii H., Tohyama M., Tabira T., and Takeda M. Altered localization of amyloid precursor protein under endoplasmic reticulum stress. Biochem. Biophys. Res. Commun. 344 (2006) 525-530
104. Kuhn W., Winkel R., Woitalla D., Meves S., Przuntek H., and Muller T. High prevalence of parkinsonism after occupational exposure to lead-sulfate batteries. Neurology 50 (1998) 1885-1886
105. Lasley S.M., and Gilbert M.E. Presynaptic glutamatergic function in hippocampal dentate gyrus is diminished by chronic exposure to inorganic lead. Brain Res. 736 (1996) 125-134
106. Lasley S.M., and Gilbert M.E. Lead inhibits the rat N-methyl-d-aspartate receptor channel by binding to a site distinct from the zinc allosteric site. Toxicol. Appl. Pharmacol. 159 (1999) 224-233
107. Lasley S.M., and Gilbert M.E. Glutamatergic components underlying lead-induced impairments in hippocampal synaptic plasticity. Neurotoxicology 21 (2000) 1057-1068
108. Lasley S.M., and Gilbert M.E. Rat hippocampal glutamate and GABA release exhibit biphasic effects as a function of chronic lead exposure level. Toxicol. Sci. 66 (2002) 139-147
109. Lasley S.M., and Gilbert M.E. Impairment of synaptic function by exposure to lead. In: Tiffany-Castiglioni E. (Ed). In Vitro Neurotoxicology: Principles and Challenges (2004), Humana Press, Totowa, N.J. 217-241
110. Lasley S.M., Green M.C., and Gilbert M.E. Influence of exposure period on in vivo hippocampal glutamate and GABA release in rats chronically exposed to lead. Neurotoxicology 20 (1999) 619-630
111. Lasley S.M., Green M.C., and Gilbert M.E. Rat hippocampal N-methyl-d-aspartate receptor binding as a function of the level of chronic lead exposure. Neurotoxicol. Teratol. 23 (2001) 185-189
112. Lee M.H., and Rabe A. Premature decline in Morris water maze performance of aging micrencephalic rats. Neurotoxicol. Teratol. 14 (1992) 383-392
113. Legare M.E., Barhoumi R., Burghardt R.C., and Tiffany-Castiglioni E. Low-level lead exposure in cultured astroglia: identification of cellular targets with vital fluorescent probes. Neurotoxicology 14 (1993) 267-272
114. 2+ entry into cultured astroglia. Toxicol. Sci. 46 (1998) 90-100
115. Lillycrop K.A., Phillips E.S., Jackson A.A., Hanson M.A., and Burdge G.C. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J. Nutr. 135 (2005) 1382-1386
116. Lindahl L.S., Bird L., Legare M.E., Mikeska G., Bratton G.R., and Tiffany-Castiglioni E. Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicol. Sci. 50 (1999) 236-243
117. Little E., Ramakrishnan M., Roy B., Gazit G., and Lee A.S. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 4 (1994) 1-18
118. Liu C.Y., Schroder M., and Kaufman R.J. Ligand-independent dimerization activates the stress response kinases IRE1 and PERK in the lumen of the endoplasmic reticulum. J. Biol. Chem. 275 (2000) 24881-24885
119. Lledo P.M., Alonso M., and Grubb M.S. Adult neurogenesis and functional plasticity in neuronal circuits. Nat. Rev., Neurosci. 7 (2006) 7179-7193
120. Lukiw W.J., Rogaev E.I., Wong L., Vaula G., McLachlan D.R., and St. George Hyslop P. Protein-DNA interactions in the promoter region of the amyloid precursor protein (APP) gene in human neocortex. Mol. Brain Res. 22 (1994) 121-131
121. Lupien S.J., King S., Meaney M.J., and McEwen B.S. Child's stress hormone levels correlate with mother's socioeconomic status and depressive state. Biol. Psychiatry 48 (2000) 976-980
122. Lupien S.J., King S., Meaney M.J., and McEwen B.S. Can poverty get under your skin? Basal cortisol levels and cognitive function in children from low and high socioeconomic status. Dev. Psychopathol. 13 (2001) 653-676
123. Major R.H. Some landmarks in the history of lead poisoning. Ann. Med. Hist. 3 (1931) 218-227
124. Mancini D.N., Singh S.M., Archer T.K., and Rodenhiser D.I. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene 18 (1999) 4108-4119
125. Manea-Krichten M., Patterson C., Miller G., Settle D., and Erel Y. Comparative increases of lead and barium with age in human tooth enamel, rib and ulna. Sci. Total Environ. 107 (1991) 179-203
126. Massicotte G., and Baudry M. Triggers and substrates of hippocampal synaptic plasticity. Neurosci. Biobehav. Rev. 15 (1991) 415-423
127. Massie H.R., and Aiello V.R. Lead accumulation in the bones of aging male mice. Gerontology 38 (1992) 13-17
128. Masters C.L., Simms G., Weinmann N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core proteins in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 4245-4249
129. Matthies H., Frey U., Reymann K., Krug M., Jork R., and Schroeder H. Different mechanisms and multiple stages of LTP. Adv. Exp. Med. Biol. 268 (1990) 359-368
130. McCauley P.T., Bull R.J., Tonti A.P., Lutkenhoff S.D., Meister M.V., Doerger J.U., and Stober J.A. The effect of prenatal and postnatal lead exposure on neonatal synaptogenesis in rat cerebral cortex. J. Toxicol. Environ. Health 10 (1982) 639-651
131. McCormick T.S., McColl K.S., and Distelhorst C.W. Mouse lymphoma cells destined to undergo apoptosis in response to thapsigargin treatment fail to generate a calcium-mediated grp78/grp94 stress response. J. Biol. Chem. 272 (1997) 6087-6092
132. McNaughton B.L. The mechanism of expression of long-term enhancement of hippocampal synapses: current issues and theoretical implications. Annu. Rev. Physiol. 55 (1993) 375-396
133. Menke A., Muntner P., Batuman V., Silbergeld E.K., and Guallar E. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation 114 (2006) 1388-1394
134. Milici A., Salbaum J.M., and Beyereuther K. Study of the Alzheimer's A4 precursor gene promoter region by genomic sequencing using Taq polymerase. Biochem. Biophys. Res. Commun. 169 (1990) 46-50
135. Ming G.L., and Song H. Adult neurogenesis in the mammalian central nervous system. Annu. Rev. Neurosci. 28 (2005) 223-250
136. Minnema D.J., Michaelson I.A., and Cooper G.P. Calcium efflux and neurotransmitter release from rat hippocampal synaptosomes exposed to lead. Toxicol. Appl. Pharmacol. 92 (1988) 351-357
137. Momcilovic B., Alkhatib H.A., Duerre J.A., Cooley M., Long W.M., Harris T.R., and Lykken G.I. Environmental lead-210 and bismuth-210 accrue selectively in the brain proteins in Alzheimer disease and brain lipids in Parkinson disease. Alzheimer Dis. Assoc. Disord. 15 (2001) 106-115
138. Morgan R.E., Levitsky D.A., and Strupp B.J. Effects of chronic lead exposure on learning and reaction time in a visual discrimination task. Neurotoxicol. Teratol. 22 (2000) 337-345
139. Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101 (2000) 451-454
140. Morris R.G., Anderson E., Lynch G.S., and Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5. Nature 319 (1986) 774-776
141. Nagane Y., Utsugisawa K., and Tohgi H. PCR amplification in bisulfite methylcytosine mapping in the GC-rich promoter region of amyloid precursor protein gene in autopsy human brain. Brain Res. Brain Res. Protoc. 5 (2000) 167-171
142. Nakajima K., and Kohsaka S. Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4 (2004) 65-84
143. 2+ exposure alters the lens alpha A-crystallin protein profile in vivo and induces cataract formation in lens organ culture. Toxicology 212 (2005) 1-9
144. Nihei M.K., Desmond N.L., McGlothan J.L., Kuhlmann A.C., and Guilarte T.R. N-Methyl-d-aspartate receptor subunit changes are associated with lead-induced deficits of long-term potentiation and spatial learning. Neuroscience 99 (2000) 233-242
145. Niklowitz W.J., and Mandybur T.I. Neurofibrillary changes following childhood lead encephalopathy. J. Neuropathol. Exp. Neurol. 34 (1975) 445-455
146. Niwa M., Sidrauski C., Kaufman R.J., and Walter P. A role for presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the mammalian unfolded protein response. Cell 99 (1999) 691-702
147. Okamura K., Kimata Y., Higashio H., Tsuru A., and Kohno K. Dissociation of Kar2p/BiP from an ER sensory molecule, Ire1p, triggers the unfolded protein response in yeast. Biochem. Biophys. Res. Commun. 279 (2000) 445-450
148. Omelchenko I.A., Nelson C.S., Marino J.L., and Allen C.N. The sensitivity of N-methyl-d-aspartate receptors to lead inhibition is dependent on the receptor subunit composition. J. Pharmacol. Exp. Ther. 278 (1996) 15-20
149. Omelchenko I.A., Nelson C.S., and Allen C.N. Lead inhibition of N-methyl-d-aspartate receptors containing NR2A, NR2C and NR2D subunits. J. Pharmacol. Exp. Ther. 282 (1997) 1458-1464
150. Patrick G.W., and Anderson W.J. Dendritic alterations of cortical pyramidal neurons in postnatally lead-exposed kittens: a Golgi-Cox study. Dev. Neurosci. 17 (1995) 219-229
151. Pavelko K.D., Howe C.L., Drescher K.M., Gamez J.D., Johnson A.J., Wei T., Ransohoff R.M., and Rodriguez M. Interleukin-6 protects anterior horn neurons from lethal virus-induced injury. J. Neurosci. 23 (2003) 481-492
152. Penkowa M., Camats J., Hadberg H., Quintana A., Rojas S., Giralt M., Molinero A., Campbell I.L., and Hidalgo J. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide. J. Neurosci. Res. 73 (2003) 481-496
153. Pentreath V.W. Neurotoxicology In Vitro (1999), Taylor & Francis, Philadelphia
154. Pizzi M., Sarnico I., Boroni F., Benarese M., Dreano M., Garotta G., Valerio A., and Spano P. Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Mol. Cell. Neurosci. 25 (2004) 301-311
155. Poirier L.A., and Vlasova T.I. The prospective role of abnormal methyl metabolism in cadmium toxicity. Environ. Health Perspect. 10 (2002) 793-795
156. Pollwein P., Masters C., and Beyruther K. The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter. Nucleic Acids Res. 20 (1992) 63-68
157. Preti A. Fetal hypoxia, genetic risk, and schizophrenia. Am. J. Psychiatry 160 (2003) 1186
158. Qian Y.C., and Tiffany-Castiglioni E. Lead-induced endoplasmic reticulum (ER) stress responses in the nervous system. Neurochem. Res. 28 (2003) 153-162
159. Qian Y.C., Tiffany-Castiglioni E., and Harris E.D. Copper transport and kinetics in cultured C6 rat glioma cells. Am. J. Physiol. 269 (1995) C892-C898
160. Qian Y.C., Mikeska G., Harris E.D., Bratton G.R., and Tiffany-Castiglioni E. Effect of lead exposure and accumulation on copper homeostasis in cultured C6 rat glioma cells. Toxicol. Appl. Pharmacol. 158 (1999) 41-49
161. Qian Y.C., Harris E.D., Zheng Y., and Tiffany-Castiglioni E. Lead
162. Qian Y.C., Falahatpisheh M.H., Zheng Y., Ramos K.S., and Tiffany-Castiglioni E. Induction of 78 kD glucose-regulated protein (GRP78) expression and redox-regulated transcription factor activity by lead and mercury in C6 rat glioma cells. Neurotox. Res. 3 (2001) 581-589
163. Qian Y.C., Zheng Y., Ramos K.S., and Tiffany-Castiglioni E. GRP78 compartmentalized redistribution in Pb-treated glia: role of GRP78 in lead-induced oxidative stress. Neurotoxicology 26 (2005) 267-275
164. Qian Y.C., Zheng Y., Weber D., and Tiffany-Castiglioni E. A 78-kDa glucose-regulated protein is involved in the decrease of interleukin-6 secretion by lead treatment from astrocytes. Am. J. Physiol., Cell Physiol. 293 (2007) C897-C905
165. Querfurth H.W., Jiang J., Xia W., and Selkoe D.J. Enhancer function and novel DNA binding protein activity in the near upstream betaAPP gene promoter. Gene 232 (1999) 125-141
166. Racine R.J., Moore K.A., and Wicks S. Activation of the NMDA receptor: a correlate in the dentate gyrus field potential and its relationship to long-term potentiation and kindling. Brain Res. 556 (1991) 226-239
167. Raiha I., Kaprio J., Koskenvuo M., Rajala T., and Sourander L. Alzheimer's disease in twins. Biomed. Pharmacother. 51 (1997) 101-104
168. Rao R.V., and Bredesen D.E. Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr. Opin. Cell Biol. 16 (2004) 653-662
169. Reddy R.K., Mao C., Baumeister P., Austin R.C., Kaufman R.J., and Lee A.S. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J. Biol. Chem. 278 (2003) 20915-20924
170. Reeves R., Thiruchelvam M., Richfield E.K., and Cory-Slechta D.A. Behavioral sensitization and long-term neurochemical alterations associated with the fungicide triadimefon. Pharmacol. Biochem. Behav. 76 (2003) 315-326
171. Reuhl K.R. Delayed expression of neurotoxicity: the problem of silent damage. Neurotoxicology 12 (1991) 341-346
172. Rex C.S., Lauterborn J.C., Lin C.Y., Kramar E.A., Rogers G.A., Gall C.M., and Lynch G. Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor. J. Neurophysiol. 96 (2006) 677-685
173. Reyes P.F., Gonzalez C.F., Zalewska M.K., and Besarab A. Intracranial calcification in adults with chronic lead exposure. Am. J. Roentgenol. 146 (1986) 267-270
174. Reymann K.G., and Frey J.U. The late maintenance of hippocampal LTP: requirements, phases, 'synaptic tagging', 'late-associativity' and implications. Neuropharmacology 52 (2007) 24-40
175. Rice D.C. Delayed neurotoxicity in monkeys exposed developmentally to methylmercury. Neurotoxicology 10 (1989) 645-650
176. Riedel G., Wetzel W., and Reymann K.G. Comparing the role of metabotropic glutamate receptors in long-term potentiation and in learning and memory. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 20 (1996) 761-789
177. Robakis N.K., Ramakrishna N., Wolfe G., and Wisniewski H.M. Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 4190-4194
178. Robinson G.B., and Reed G.D. Effect of MK-801 on the induction and subsequent decay of long-term potentiation in the unanesthetized rabbit hippocampal dentate gyrus. Brain Res. 569 (1992) 78-85
179. Rogaev E.I., Lukiw W.J., Lavrushina O., Rogaeva E.A., and St George-Hyslop P.H. The upstream promoter of the beta-amyloid precursor protein gene (APP) shows differential patterns of methylation in human brain. Genomics 22 (1994) 340-347
180. Rogan W.J., Dietrich K.N., Ware J.H., Docker D.W., Salganik M., Radcliffe J., Jones R.L., Ragan N.B., Chisolm Jr. J.J., and Rhoads G.G. Treatment of lead-exposed children trial group. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N. Engl. J. Med. 344 (2001) 1421-1426
181. Rowles T.K., Womac C., Bratton G.R., and Tiffany-Castiglioni E. Interaction of lead and zinc in cultured astroglia. Metab. Brain Dis. 4 (1989) 187-201
182. Salbaum J.M., Weidemann A., Masters C.L., and Beyreuther K. The promoter of Alzheimer's disease amyloid A4 precursor gene. Prog. Clin. Biol. Res. 317 (1989) 277-283
183. Schaumberg D.A., Mendes F., Balaram M., Dana M.R., Sparrow D., and Hu H. Accumulated lead exposure and risk of age-related cataract in men. JAMA 292 (2004) 2750-2754
184. Schneider J.S., Anderson D.W., Wade T.V., Smith M.G., Leibrandt P., Zuck L., and Lidsky T.I. Inhibition of progenitor cell proliferation in the dentate gyrus of rats following post-weaning lead exposure. Neurotoxicology 26 (2005) 141-145
185. Seckl J.R., and Meaney M.J. Glucocorticoid programming. Ann. N.Y. Acad. Sci. 1032 (2004) 63-84
186. Selkoe D.J. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol. 6 (2004) 1054-1061
187. Selkoe D.J., Abraham C.R., Podlisny M.B., and Duffy L.K. Isolation of low-molecular-weight proteins from amyloi4 plaque fibers in Alzheimer's disease. J. Neurochem. 46 (1986) 1820-1834
188. Sierra E.M., and Tiffany-Castiglioni E. Reduction of glutamine synthetase activity in astroglia exposed in culture to low levels of inorganic lead. Toxicology 65 (1991) 295-304
189. Silbergeld E.K. Facilitative mechanisms of lead as a carcinogen. Mutat. Res. 533 (2003) 121-133
190. Stangle D.E., Strawderman M.S., Smith D., Kuypers M., and Strupp B.J. Reductions in blood lead overestimate reductions in brain lead following repeated succimer regimens in a rodent model of childhood lead exposure. Environ. Health Perspect. 112 (2004) 302-308
191. Steptoe A., Cropley M., Griffith J., and Kirschbaum C. Job strain and anger expression predict early morning elevation in salivary cortisol. Psychosom. Med. 62 (2000) 286-292
192. Stewart W.F., Schwartz B.S., Simon D., Kelsey K., and Todd A.C. ApoE genotype, past adult lead exposure, and neurobehavioral function. Environ. Health Perspect. 110 (2002) 501-505
193. Stewart W.F., Schwartz B.S., Davatzikos C., Shen D., Liu D., Wu X., Todd A.C., Shi W., Bassett S., and Youssem D. Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology 66 (2006) 1476-1484
194. Sui L., Ge S.Y., Ruan D.Y., Chen J.T., Xu Y.Z., and Wang M. Age-related impairment of long-term depression in area CA1 and dentate gyrus of rat hippocampus following developmental lead exposure in vitro. Neurotoxicol. Teratol. 22 (2000) 381-387
195. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos Jr. L., Eckman C., Golde T.E., and Younkin S.G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264 (1994) 1336-1340
196. Taga T., and Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15 (1997) 797-819
197. Takiguchi M., Achanzar W.E., Qu W., Li G., and Waalkes M.P. Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res. 286 (2003) 355-365
198. Tang H.W., Yan H.L., Hu X.H., Liang Y.X., and Shen X.Y. Lead cytotoxicity in primary cultured rat astrocytes and Schwann cells. J. Appl. Toxicol. 16 (1996) 187-196
199. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A., St George-Hyslop P., Van Keuren M.L., Patterson D., Pagan S., Kurnit D.M., and Neve R.L. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235 (1987) 880-884
200. Tavakoli-Nezhad M., Barron A.J., and Pitts D.K. Postnatal inorganic lead exposure decreases the number of spontaneously active midbrain dopamine neurons in the rat. Neurotoxicology 22 (2001) 259-269
201. Teismann P., Tieu K., Cohen O., Choi D.K., Wu du C., Marks D., Vila M., Jackson-Lewis V., and Przedborski S. Pathogenic role of glial cells in Parkinson's disease. Mov. Disord. 18 (2003) 121-129
202. Thiruchelvam M., Richfield E.K., Goodman B.M., Baggs R.B., and Cory-Slechta D.A. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 23 (2002) 621-633
203. Tiffany-Castiglioni E. In Vitro Neurotoxicology: Principles and Challenges (2004), Humana Press, Totowa, NJ
204. Tiffany-Castiglioni E., and Qian Y.C. Cell-type-specific responses of the nervous system to lead. In: Tiffany-Castiglioni E. (Ed). In Vitro Neurotoxicology: Principles and Challenges (2004), Humana Press, Totowa, NJ 151-186
205. Tiffany-Castiglioni E., and Qian Y.C. Chapter 26. Astroglia and lead neurotoxicity. In: Aschner M., and Costa L.G. (Eds). The Role of Glia in Neurotoxicity (2005), CRC Press, Boca Raton 417-437
206. Tiffany-Castiglioni E., Zmudzki J., Wu J.N., and Bratton G.R. Effects of lead treatment on intracellular iron and copper concentrations in cultured astroglia. Metab. Brain Dis. 2 (1987) 61-79
207. Tiffany-Castiglioni E., Sierra E.M., Wu J.N., and Rowles T.K. Lead toxicity in neuroglia. Neurotoxicology 10 (1989) 417-443
208. Tiffany-Castiglioni E., Garcia D.M., Wu J.N., Zmudzki J., and Bratton G.R. Effects of lead on viability and intracellular metal content of C6 rat glioma cells. J. Toxicol. Environ. Health 23 (1988) 267-279
209. Tiffany-Castiglioni E., Hong S., Qian Y.C., Tang Y., and Donnelly K.C. In vitro models for assessing neurotoxicity of mixtures. Neurotoxicology 27 (2006) 835-839
210. Tiffany-Castiglioni E., Venkatraj V., Qian Y.C., and Wild J.R. Chapter 22. In vitro models for testing organophosphate-induced neurotoxicity and remediation. In: Gupta R.C. (Ed). Toxicology of Organophosphate and Carbamate Compounds (2006), Elsevier Academic Press, Amsterdam 315-337
211. Tohgi H., Utsugisawa K., Nagane Y., Yoshimura M., Genda Y., and Ukitsu M. Reduction with age in methylcytosine in the promoter region - 224 approximately - 101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res. Mol. Brain Res. 70 (1999) 288-292
212. Ujihara H., and Albuquerque E.X. Developmental change of the inhibition by lead of NMDA-activated currents in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 263 (1992) 868-875
213. U.S. Environmental Protection Agency (US EPA) 1977, Air quality criteria for lead. Research Triangle Park, NC: Health Effects Research Laboratory, Criteria and Special Studies Office, EPA report n. EPA-600/877-017. Available from: NTIS, Springfield, VA; PB-280411.
214. U.S. Environmental Protection Agency, 1986, Air quality criteria for lead. Research Triangle Park, NC: Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office; EPA report no. EPA-600/8-83/028aF-dF. 4v. Available from: NTIS, Springfield, VA; PB87-142378.
215. U.S. Environmental Protection Agency, 2006. Air Quality Criteria for Lead, Volume I and II of II. Research Triangle Park, NC: National Center for Environmental Assessment - RTP Office. Available at: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=15882.
216. Valdez R., Athens M.A., Thompson G.H., Bradshaw B.S., and Stern M.P. Birth weight and adult health outcomes in a biethnic population in the USA. Diabetologia 37 (1994) 624-631
217. Vaziri N.D. Pathogenesis of lead-induced hypertension: role of oxidative stress. J. Hypertens., Suppl. 20 (2002) S15-S20
218. Verina T., Rohde C.A., and Guilarte T.R. Environmental lead exposure during early life alters granule cell neurogenesis and morphology in the hippocampus of young adult rats. Neuroscience 145 (2007) 1037-1047
219. Virgolini M.B., Chen K., Weston D.D., Bauter M.R., and Cory-Slechta D.A. Interactions of chronic lead exposure and intermittent stress: consequences for brain catecholamine systems and associated behaviors and HPA axis function. Toxicol. Sci. 87 (2005) 469-482
220. Virgolini M.B., Bauter M.R., Weston D.D., and Cory-Slechta D.A. Permanent alterations in stress responsivity in female offspring subjected to combined maternal lead exposure and/or stress. Neurotoxicology 27 (2006) 11-21
221. Vyskocil A., Fiala Z., Ettlerova E., and Tenjnorova I. Influence of chronic lead exposure on hormone levels in developing rats. J. Appl. Toxicol. 10 (1990) 301-302
222. Vyskocil A., Fiala Z., Lacinova V., and Ettlerova E. A chronic study with lead acetate in female rats. J. Appl. Toxicol. 11 (1991) 385-386
223. Vyskocil A., Fiala Z., Tejnorova I., and Tusl M. Stress reaction in developing rats exposed to 1% lead acetate. Sb. Ved. Pr. Lek. Fak. Univ. Karlovy Hradci Kral. 34 (1991) 287-295
224. Vyskocil A., Smejkalova J., and Lacinova V. Dose-related stress reaction in male rats chronically exposed to lead acetate. Sb. Ved. Pr. Lek. Fak. Univ. Karlovy Hradci Kral. 34 (1991) 393-401
225. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., Dymov S., Szyf M., and Meaney M.J. Epigenetic programming by maternal behavior. Nat. Neurosci. 7 (2004) 847-854
226. Wickner S., Maurizi M.R., and Gottesman S. Posttranslational quality control: folding, refolding, and degrading proteins. Science 286 (1999) 1888-1893
227. Wild-Bode C., Yamazaki T., Capell A., Leimer U., Steiner H., Ihara Y., and Haass C. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J. Biol. Chem. 272 (1997) 16085-16088
228. Wilson M.A., Johnston M.V., Goldstein G.W., and Blue M.E. Neonatal lead exposure impairs development of rodent barrel field cortex. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5540-5545
229. Windebank A.J. Specific inhibition of myelination by lead in vitro; comparison with arsenic, thallium, and mercury. Exp. Neurol. 94 (1986) 203-212
230. Wong W.K., Chen K., and Shih J.C. Decreased methylation and transcription repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation. J. Biol. Chem. 278 (2003) 36227-36235
231. Yang Y., Turner R.S., and Gaut J.R. The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Abeta40 and Abeta42 secretion. J. Biol. Chem. 273 (1998) 25552-25555
232. Yarbrough D.E., Barrett-Connor E., Kritz-Silverstein D., and Wingard D.L. Birth weight, adult weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho Bernardo Study. Diabetes Care 21 (1998) 1652-1658
233. Yu Z., Luo H., Fu W., and Mattson M.P. The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp. Neurol. 155 (1999) 302-314
234. Zawia N.H., and Basha M.R. Environmental risk factors and the developmental basis for Alzheimer's disease. Rev. Neurosci. 16 (2005) 325-337
235. Zhao B., and Schwartz J.P. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J. Neurosci. Res. 52 (1998) 7-16
236. Zhang K., and Kaufman R.J. Signaling the unfolded protein response from the endoplasmic reticulum. J. Biol. Chem. 279 (2004) 25935-25938
237. Zhang X.Y., Liu A.P., Ruan D.Y., and Liu J. Effect of developmental lead exposure on the expression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal rats by digoxigenin-labeled in situ hybridization histochemistry. Neurotoxicol. Teratol. 24 (2005) 149-160
238. Zhu W.G., Srinivasan K., Dai Z., Duan W., Druhan L.J., Ding H., Yee L., Villalona-Calero M.A., Plass C., and Otterson G.A. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol. Cell. Biol. 23 (2003) 4056-4065